MDXG Mimedx Group, Inc.

$4.43 -2.85%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Mimedx Group, Inc. (MDXG) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $646 million. Shares last traded at $4.43, 44.6% below their 52-week high. Over the past year the stock is down 37.5%. MDXG trades at a price-to-earnings ratio of 103.50, above the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 1.8%, above the peer median of -9.3%. Revenue grew 20.0% year over year.

Market Cap

$646M

Shares Out

145.8M

EPS (TTM)

$0.09

P/E Ratio

49.22

P/S Ratio

1.82

P/B Ratio

2.99

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.00

52-Week Low

$3.02

Volume

66,459

Avg Vol (3m)

105,135.27

Performance

-1.99%

+6.75%

+16.89%

-6.74%

YTD

-31.64%

-37.52%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

54.00

SMA (50)

$4.25

SMA (200)

$4.73

Price vs SMA50

+4.32%

Price vs SMA200

-6.27%

ATR (14)

$0.20

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$355M

Net Income

$6M

Gross Margin

78.8%

Operating Margin

2.5%

Net Margin

1.8%

Return on Equity

2.9%

Return on Assets

2.2%

Current Ratio

5.33

Debt / Equity

0.07

Revenue Growth (YoY)

+20.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.17	2026-07-29
Q1 2026	$-0.07	2026-04-29
FY 2025	$0.32	2026-02-25
Q3 2025	$0.22	2025-10-29
Q2 2026	$0.11	2026-07-29
Q1 2026	$0.05	2026-04-29

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

MDXG vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

103.50 / 28.18 med

+267% premium

P/S vs peers

1.82 / 2.94 med

-38% discount

Net margin vs peers

1.8% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.